BIOPHARMA

Bring New Therapies to Market Faster.

BIOPHARMA
Bring New Therapies to Market Faster.

Find and eradicate trial inefficiencies

Design successful protocols

Design clinical trial protocols with instant feedback about their feasibility.

Improve planning and feasibility

Improve planning & site selection

Instantly see a list of sites that match your criteria, along with the number of patients that match and a comprehensive aggregated picture of the cohort.

Have a direct path to real patients

Have a path to real patients

Identify sites that definitively have patients, based on real data. Gain a path back to the identity of the patient if the healthcare organization decides to participate in your trial.

The TriNetX Network

Bringing together healthcare organizations, biopharma and CROs.

Access to a network of 84 million patients for research, driven and refreshed by healthcare organization EMRs.

Study millions of real-world patients, including hard-to-find patients with rare diseases.

Identify sites with access to a sufficient number of patients that meet your inclusion and exclusion criteria.

TriNetX

TriNetX LiveTM

The industry’s leading cloud-based health research platform.

Gain real-time responses and insights into protocol feasibility.

R

Real-time scenario modeling for protocol feasibility.

R

Pre-qualified, identified patient lists.

R

Predictive analytics to project rates at which new patients match your criteria.

R

Simple to use.

TriNetX-Screen

TriNetX represents the future of a data-driven approach to clinical trial design and research. This collaboration is an important part of the innovations we have been making at Celgene to realize the power of data analytics within our clinical research organization.

Jay Kaminski

Senior Vice President, Global Clinical Research Development and Operations, Celgene